CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

Despite recent therapeutic advances, the prognosis of multiple myeloma (MM) patients remains poor. Thus, new strategies to improve outcomes are imperative. Chimeric antigen receptor (CAR) T-cell therapy has changed the treatment landscape of B-cell malignancies, providing a potentially curative opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Lobato, Luis Gerardo, Ganzetti, Maya, Fernández de Larrea, Carlos, Hudecek, Michael, Einsele, Hermann, Danhof, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399644/
https://www.ncbi.nlm.nih.gov/pubmed/32850376
http://dx.doi.org/10.3389/fonc.2020.01243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399644/
https://www.ncbi.nlm.nih.gov/pubmed/32850376
http://dx.doi.org/10.3389/fonc.2020.01243

Ejemplares similares